107 related articles for article (PubMed ID: 15740139)
1. beta-Sheet ligands in action: KLVFF recognition by aminopyrazole hybrid receptors in water.
Rzepecki P; Schrader T
J Am Chem Soc; 2005 Mar; 127(9):3016-25. PubMed ID: 15740139
[TBL] [Abstract][Full Text] [Related]
2. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
[TBL] [Abstract][Full Text] [Related]
3. Rational design of β-sheet ligands against Aβ42-induced toxicity.
Hochdörffer K; März-Berberich J; Nagel-Steger L; Epple M; Meyer-Zaika W; Horn AH; Sticht H; Sinha S; Bitan G; Schrader T
J Am Chem Soc; 2011 Mar; 133(12):4348-58. PubMed ID: 21381732
[TBL] [Abstract][Full Text] [Related]
4. New heterocyclic beta-sheet ligands with peptidic recognition elements.
Rzepecki P; Gallmeier H; Geib N; Cernovska K; König B; Schrader T
J Org Chem; 2004 Aug; 69(16):5168-78. PubMed ID: 15287758
[TBL] [Abstract][Full Text] [Related]
5. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
6. Simulation study on the disordered state of an Alzheimer's beta amyloid peptide Abeta(12 36) in water consisting of random-structural, beta-structural, and helical clusters.
Ikebe J; Kamiya N; Ito J; Shindo H; Higo J
Protein Sci; 2007 Aug; 16(8):1596-608. PubMed ID: 17656579
[TBL] [Abstract][Full Text] [Related]
7. Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context.
Gibson TJ; Murphy RM
Biochemistry; 2005 Jun; 44(24):8898-907. PubMed ID: 15952797
[TBL] [Abstract][Full Text] [Related]
8. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.
Sciarretta KL; Boire A; Gordon DJ; Meredith SC
Biochemistry; 2006 Aug; 45(31):9485-95. PubMed ID: 16878983
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization of a soluble amyloid beta-peptide oligomer.
Yu L; Edalji R; Harlan JE; Holzman TF; Lopez AP; Labkovsky B; Hillen H; Barghorn S; Ebert U; Richardson PL; Miesbauer L; Solomon L; Bartley D; Walter K; Johnson RW; Hajduk PJ; Olejniczak ET
Biochemistry; 2009 Mar; 48(9):1870-7. PubMed ID: 19216516
[TBL] [Abstract][Full Text] [Related]
10. Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
Chafekar SM; Malda H; Merkx M; Meijer EW; Viertl D; Lashuel HA; Baas F; Scheper W
Chembiochem; 2007 Oct; 8(15):1857-64. PubMed ID: 17763487
[TBL] [Abstract][Full Text] [Related]
11. The Alzheimer's peptide a beta adopts a collapsed coil structure in water.
Zhang S; Iwata K; Lachenmann MJ; Peng JW; Li S; Stimson ER; Lu Y; Felix AM; Maggio JE; Lee JP
J Struct Biol; 2000 Jun; 130(2-3):130-41. PubMed ID: 10940221
[TBL] [Abstract][Full Text] [Related]
12. Lipid-induced conformational transition of the amyloid core fragment Abeta(28-35) and its A30G and A30I mutants.
Nagarajan S; Ramalingam K; Neelakanta Reddy P; Cereghetti DM; Padma Malar EJ; Rajadas J
FEBS J; 2008 May; 275(10):2415-27. PubMed ID: 18422968
[TBL] [Abstract][Full Text] [Related]
13. Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action.
Bartolini M; Bertucci C; Bolognesi ML; Cavalli A; Melchiorre C; Andrisano V
Chembiochem; 2007 Nov; 8(17):2152-61. PubMed ID: 17939148
[TBL] [Abstract][Full Text] [Related]
14. Prevention of Alzheimer's disease-associated Abeta aggregation by rationally designed nonpeptidic beta-sheet ligands.
Rzepecki P; Nagel-Steger L; Feuerstein S; Linne U; Molt O; Zadmard R; Aschermann K; Wehner M; Schrader T; Riesner D
J Biol Chem; 2004 Nov; 279(46):47497-505. PubMed ID: 15322133
[TBL] [Abstract][Full Text] [Related]
15. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
[TBL] [Abstract][Full Text] [Related]
16. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.
Milojevic J; Esposito V; Das R; Melacini G
J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135
[TBL] [Abstract][Full Text] [Related]
17. Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils.
Chen Z; Krause G; Reif B
J Mol Biol; 2005 Dec; 354(4):760-76. PubMed ID: 16271725
[TBL] [Abstract][Full Text] [Related]
18. The metal loading ability of beta-amyloid N-terminus: a combined potentiometric and spectroscopic study of copper(II) complexes with beta-amyloid(1-16), its short or mutated peptide fragments, and its polyethylene glycol (PEG)-ylated analogue.
Damante CA; Osz K; Nagy Z; Pappalardo G; Grasso G; Impellizzeri G; Rizzarelli E; Sóvágó I
Inorg Chem; 2008 Oct; 47(20):9669-83. PubMed ID: 18808108
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy.
Whittemore NA; Mishra R; Kheterpal I; Williams AD; Wetzel R; Serpersu EH
Biochemistry; 2005 Mar; 44(11):4434-41. PubMed ID: 15766273
[TBL] [Abstract][Full Text] [Related]
20. Modulation of fibril formation by a beta-sheet breaker peptide ligand: an electrochemical approach.
Veloso AJ; Kerman K
Bioelectrochemistry; 2012 Apr; 84():49-52. PubMed ID: 21967982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
